10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
65.05%
EBIT growth above 1.5x OR's 15.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
No Data
No Data available this quarter, please select a different quarter.
-0.97%
Negative net income growth while OR stands at 26.20%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
12.50%
EPS growth at 50-75% of OR's 21.43%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
12.50%
Diluted EPS growth at 50-75% of OR's 21.43%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
14.90%
Share count expansion well above OR's 0.41%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
14.90%
Diluted share count expanding well above OR's 0.35%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
6.44%
OCF growth at 50-75% of OR's 11.49%. Martin Whitman would question if the firm lags in monetizing sales effectively.
84.59%
Positive FCF growth while OR is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-54.16%
Negative 10Y OCF/share CAGR while OR stands at 273.05%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-54.16%
Negative 5Y OCF/share CAGR while OR is at 192.29%. Joel Greenblatt would question the firm’s operational model or cost structure.
13.48%
3Y OCF/share CAGR under 50% of OR's 22738.42%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
14.04%
Below 50% of OR's 301.80%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
14.04%
Below 50% of OR's 117.59%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-304.47%
Negative 3Y CAGR while OR is 86.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-49.97%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-49.97%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-32.13%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.31%
AR growth well above OR's 8.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-1.98%
Negative asset growth while OR invests at 3.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-14.03%
We have a declining book value while OR shows 5.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-65.05%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.